TUESDAY WATCHLIST 05/26/2020
**Disclaimer: I am not a professional, I expect you to do your own research and due diligence on any investment or trade that you may perform. None of the following is financial advice in any way shape or form. Trade at your own risk.
This week could likely be the best week for Biotech of the year. Three conferences take place this week with ASCO (American Society of Clinical Oncologists, May 29th-31st) / ISCT (International Society of Cell and Gene Therapy, May 28th-29th) / ASCP (American Society for Clinical Pathology, May29th-30th). ASCO in itself is probably the biggest and most anticipated Biotech conference of the year and many many companies will be making a presentations here. Generally speaking this would mark the end of Biotech season, but due to COVID-19 I believe we can expect Biotech to run big for the remainder of the year.
$NMHLY NMC Health PLC (OTC:NMHLY): Those who know me probably have heard me talk about $NMHLY. Typical volatility for $NMHLY can easy be 20 cents +/- every day, not much you say, please realize right now its a 40 cent stock. There are no catalysts here, only class action lawsuits which is normal, especially for a healthcare provider based out of the United Arab Emirates so don't let those scare you away. $NMHLY was largely stale last week with morning spikes in the 10 cent range every day but then dropping back to r/g line and staying within 5 cents of that the remainder of the day. This is not a typical $NMHLY pattern so it scares me. The best play for $NMHLY is still the r/g pattern but I'm also looking for dip buys here. Ideally $NMHLY will continue to fade begining of the week to the .30s and .20s range and then be primed for a huge Friday/following Monday.
$CYDY CytoDyn In (OTC:CYDY): CytoDyn has had very positive results in regards to all of their drugs of recent and will be holding a conference call Tuesday May 26th at 4pm EST to provide updates on COVID-19 (Phase 2, 3 & eIND), Cancer (mTNBC, Phase 2 for 22 Solid Tumor Cancers), HIV (BLA, Monotherapy), NASH, GvHD and MS drugs/medications/treatments. Look for this to be a solid o/n play Tuesday with a sell Wednesday morning. I for one will be looking to try and catch this at its bottom Tuesday for my entry here. $CYDY should also hold well throughout the week with dip buy opportunities throughout depending on the news from the call. This is the type of call I actually would hold a position through, especially being OTC and their past performance with treaments.
$TUES Tuesday Morning Corp (NASDAQ:TUES): Tuesday Morning is being rumored to have a bankrupty filing as early as this weekend. This is already a low priced stock at .29, remembering $JCP leading up to its bankruptcy the volatility was crazy with 100% dips and bounces. Definitely keep an eye on this for any dip buy opportunities and a possible short play through the week.
$RENN Renren Inc (NYSE:RENN): Renren Inc has been on quite a tear through May, starting the month at 91 cents/share and climbing all the way to 4.50 as of recent. Just over the past three market days it has spiked all the way from 1.68 on zero news. The last real news for this company was negative, stating the negative impacts that COVID 19 would have on the company and that was on April 28th. This stock is WAY overextended, look for a short play on its FRD.
$MARK Remark Holdings (NASDAQ:MARK): $MARK Oh $MARK why do I hate thee so... Remark Holdings continues to drive off their thermal scanning technology. Numerous outlets are now being reported as clients to Remark Holdings. From what I can tell, these are all verified and legit including Disney, Comcast, and several Las Vegas Casinos to say the least. Expect a lot of volatility from $MARK in the upcoming week(s) as more and more comes out. $MARK seems to put out a new tweet every day as well and the spikes off those tweets don't seem to be slowing down. If $MARK breaks 3.20 barrier it could easily spike into the double digits as it has done previously.
Join now or log in to leave a comment